CS logo
small CS logo
Haywood Hospital

Stoke on Trent, United Kingdom
Hospital in Stoke-on-Trent, England
High Ln, Burslem, Stoke-on-Trent ST6 7AG

About Haywood Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Amgen
2
Janssen Research & Development, LLC
2
Eli Lilly and Company
1
Izana Bioscience Ltd.
1
Janssen Pharmaceutica N.V., Belgium
1
Keele University
1
Total Rows: 6

Clinical Trials at Haywood Hospital


During the past decade, Haywood Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11221100220000000022Started TrialsCompleted Trails201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
2010-09-30
2017-02-09
Completed
505
Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
2010-12-09
2017-08-16
Completed
529
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis
2017-05-09
2021-05-27
Completed
773
The MSK-Tracker Study
2018-07-10
2019-12-30
Completed
321
Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis
2018-09-06
2020-02-04
Completed
42
A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy
2019-03-22
2020-11-11
Completed
285
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
2021-08-30
2026-02-13
Recruiting
405
A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis
2021-10-14
2022-08-10
Completed
53

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Haywood Hospital" #1 sponsor was "Amgen" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Izana Bioscience Ltd." with 1 trials sponsored and "Janssen Pharmaceutica N.V., Belgium" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Haywood Hospital" #1 collaborator was "Arthritis Research UK" with 1 trials as a collaborator, "Georgina Craig Associates Limited" with 1 trials as a collaborator, "Innovate UK" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Pro-Mapp Limited Company number 10152526" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAmgen: 2Amgen: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Eli Lilly and Company: 1Eli Lilly and Company: 1Izana Bioscience Ltd.: 1Izana Bioscience Ltd.: 1Janssen PharmaceuticaN.V., Belgium: 1Janssen PharmaceuticaN.V., Belgium: 1Keele University: 1Keele University: 1

Created with Highcharts 11.1.0Top CollaboratorsArthritis Research UK: 1Arthritis Research UK: 1Georgina CraigAssociates Limited: 1Georgina CraigAssociates Limited: 1Innovate UK: 1Innovate UK: 1Iqvia Pty Ltd: 1Iqvia Pty Ltd: 1Pro-Mapp LimitedCompany number10152526: 1Pro-Mapp LimitedCompany number10152526: 1University of Oxford: 1University of Oxford: 1

Clinical Trials Conditions at Haywood Hospital


According to Clinical.Site data, the most researched conditions in "Haywood Hospital" are "Arthritis, Psoriatic" (2 trials), "Axial Spondyloarthritis" (2 trials), "Psoriatic Arthritis" (2 trials), "Arthritis, Rheumatoid" (1 trials) and "Musculoskeletal Pain" (1 trials). Many other conditions were trialed in "Haywood Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Haywood Hospital


Most popular intervention types in "Haywood Hospital" are "Drug" (6 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (7 trials), "Apremilast 20mg" (2 trials), "Apremilast 30mg" (2 trials), "Guselkumab" (1 trials) and "Guselkumab 100 mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Haywood Hospital


The vast majority of trials in "Haywood Hospital" are 8 trials for "All" genders.

Clinical Trials Status at Haywood Hospital


Currently, there are NaN active trials in "Haywood Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Haywood Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Haywood Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 2Phase 2: 2Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Recruiting: 1Recruiting: 1